Literature DB >> 31853098

MicroRNAs - diagnostic markers in Parkinson disease?

Ian Fyfe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31853098     DOI： 10.1038/s41582-019-0305-y

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  4 in total

Review 1.  Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease.

Authors:  Michele d'Angelo; Annamaria Cimini; Vanessa Castelli
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

2.  MicroRNA-6862 inhibition elevates sphingosine kinase 1 and protects neuronal cells from MPP+-induced apoptosis.

Authors:  Gang Xue; Ju-Ping Chen; Ya Li; Zhi-Qing Zhang; Jian-Liang Zhu; Wanli Dong
Journal:  Aging (Albany NY)       Date:  2020-12-19       Impact factor: 5.682

Review 3.  The Emerging Roles of the β-Secretase BACE1 and the Long Non-coding RNA BACE1-AS in Human Diseases: A Focus on Neurodegenerative Diseases and Cancer.

Authors:  Arezou Sayad; Sajad Najafi; Bashdar Mahmud Hussen; Sara Tharwat Abdullah; Ahmad Movahedpour; Mohammad Taheri; Mohammadreza Hajiesmaeili
Journal:  Front Aging Neurosci       Date:  2022-03-21       Impact factor: 5.750

Review 4.  Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option.

Authors:  Athena Starlard-Davenport; Qingqing Gu; Betty S Pace
Journal:  Mol Diagn Ther       Date:  2022-05-12       Impact factor: 4.476
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.